These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 35768809)

  • 1. The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database.
    Zheng BH; Zhang C; Wan WZ; Sun WT; Cheng X; Ni XJ; Ni XL; Suo T; Liu H; Shen S; Liu HB
    BMC Surg; 2022 Jun; 22(1):253. PubMed ID: 35768809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological characteristics of early to advanced gallbladder carcinoma and extrahepatic cholangiocarcinoma.
    Kijima H; Wu Y; Yosizawa T; Suzuki T; Tsugeno Y; Haga T; Seino H; Morohashi S; Hakamada K
    J Hepatobiliary Pancreat Sci; 2014 Jul; 21(7):453-8. PubMed ID: 24591403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery for recurrent biliary carcinoma: results for 27 recurrent cases.
    Noji T; Tsuchikawa T; Mizota T; Okamura K; Nakamura T; Tamoto E; Shichinohe T; Hirano S
    World J Surg Oncol; 2015 Feb; 13():82. PubMed ID: 25884694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative prognosis and risk assessment in gallbladder neuroendocrine neoplasms versus adenocarcinomas.
    Zhao ZH; Huang Y; Jiang C; Lv GY; Wang M
    Front Endocrinol (Lausanne); 2024; 15():1326112. PubMed ID: 38390209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma.
    Kelly KJ; Dukleska K; Kuk D; Kingham TP; D'Angelica MI; DeMatteo RP; Allen PJ; Jarnagin WR; Fong Y
    Ann Surg Oncol; 2014 Mar; 21(3):979-85. PubMed ID: 24212720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary Neuroendocrine Neoplasms: Clinical Profiles, Management, and Analysis of Prognostic Factors.
    Zheng Z; Chen C; Li B; Liu H; Zhou L; Zhang H; Zheng C; He X; Liu W; Hong T; Zhao Y
    Front Oncol; 2019; 9():38. PubMed ID: 30805307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Landscape of distant metastasis mode and current chemotherapy efficacy of the advanced biliary tract cancer in the United States, 2010-2016.
    Wang J; Bo X; Nan L; Wang CC; Gao Z; Suo T; Ni X; Liu H; Lu P; Wang Y; Liu H
    Cancer Med; 2020 Feb; 9(4):1335-1348. PubMed ID: 31876990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine neoplasm of the gallbladder: Clinical features, surgical efficacy, and prognosis.
    Wu X; Li B; Hong T; Liu W; He X; Zheng C
    Cancer Med; 2023 May; 12(10):11344-11350. PubMed ID: 36952352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precancerous lesions of the biliary tree.
    Klöppel G; Adsay V; Konukiewitz B; Kleeff J; Schlitter AM; Esposito I
    Best Pract Res Clin Gastroenterol; 2013 Apr; 27(2):285-97. PubMed ID: 23809246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
    World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is para-aortic lymph node metastasis a contraindication for radical resection in biliary carcinoma?
    Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Sakabe R; Kobayashi H; Sueda T
    World J Surg; 2011 May; 35(5):1085-93. PubMed ID: 21400012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of extrahepatic bile duct resection for T2 gallbladder cancer using data from the Japanese Biliary Tract Cancer Registry between 2014 and 2018.
    Kato H; Horiguchi A; Ishihara S; Nakamura M; Endo I
    J Hepatobiliary Pancreat Sci; 2023 Dec; 30(12):1316-1323. PubMed ID: 37792631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features and survival for gallbladder NEN: a population-based study.
    Cen D; Liu H; Wan Z; Lin Z; Wang Y; Xu J; Liang Y
    Endocr Connect; 2019 Sep; 8(9):1273-1281. PubMed ID: 31398710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
    J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological characteristics of biliary neuroendocrine neoplasms: a multicenter study.
    Lee KJ; Cho JH; Lee SH; Lee KH; Park BK; Lee JK; Woo SM; Ryu JK; Lee JK; Kim YS; Kim JW; Lee WJ
    Scand J Gastroenterol; 2017 Apr; 52(4):437-441. PubMed ID: 27924650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synchronous primary tumors of the extrahepatic bile duct and gallbladder.
    Kurosaki I; Watanabe H; Tsukada K; Hatakeyama K
    J Surg Oncol; 1997 Aug; 65(4):258-62. PubMed ID: 9274790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of neuroendocrine carcinoma in the hepatic hilar lymph nodes concomitant with an adenocarcinoma of the gallbladder.
    Okada H; Uchida Y; Matsuzaki N; Goto T; Nishimura S; Kurita A; Nishimura T; Yazumi S; Terajima H
    World J Surg Oncol; 2016 Nov; 14(1):284. PubMed ID: 27842605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of postoperative infection after resection of biliary malignancy: A multicenter retrospective cohort study.
    Iseki M; Mizuma M; Unno M; Maruyama H; Akagi S; Shimoda M; Uemura K; Inoue T; Shiomi H; Watanabe M; Kobayashi M; Matsuda A; Mizuuchi Y; Aoki T; Shinkawa H; Takahata R; Makino K; Arai H; Yokoyama Y; Takeda S; Yaguchi Y; Kitagawa Y
    Surgery; 2023 Nov; 174(5):1145-1152. PubMed ID: 37599194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of hepatopancreatoduodenectomy as a treatment modality for bile duct and gallbladder cancer.
    Lim CS; Jang JY; Lee SE; Kang MJ; Kim SW
    J Gastrointest Surg; 2012 May; 16(5):1012-8. PubMed ID: 22271243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.